Zafrira Avnur serves as Executive at Eloxx Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Zafrira Avnur has executed 2 insider transactions totaling $21.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 26, 2018 involved purchasing 2,000 shares valued at $19.0K.
Zafrira Avnur currently holds 2,263 shares of Eloxx Pharmaceuticals, Inc. (ELOX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Zafrira Avnur has been a net buyer of ELOX stock. They have purchased $21.0K and sold $0 worth of shares.
Zafrira Avnur's most recent insider trade was on Mar 26, 2018, when they purchased 2,000 shares at $9.49 per share.
Get notified when new Form 4 filings are submitted
| $7.60 |
| Discretionary |